1. DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn's and Colitis Organisation study. (16th January 2018) Authors: Kopylov, U; Verstockt, B; Biedermann, L; Sebastian, S; Pugliese, D; Sonnenberg, E; Steinhagen, P R; Arebi, N; Ron, Y; Kucharzik, T; Roblin, X; Ungar, B; Bar-Gil Shitrit, A; Ardizzone, S; Molander, P; Coletta, M; Peyrin-Biroulet, L; Bossuyt, P; Avni-Biron, I; Tsoukal, E I Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP65 Dietary therapy with the Crohn's Disease exclusion diet induces sustained clinical and endoscopic remission in adults with Mild to Moderate Crohn's Disease: Results from the CDED-AD trial. (27th May 2021) Authors: Yanai, H; Levine, A; Hirsch, A; Sigall Boneh, R; Kopylov, U; Banai Eran, H; Cohen, N A; Ron, Y; Goren, I; Leibovitzh, H; Wardi, J; Zittan, E; Ziv-Baran, T; Abramas, L; Fliss-Isakov, N; Raykhel, B; Pfeffer Gik, T; Dotan, I; Maharshak, N Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP68 Assessment of patients' understanding of Inflammatory Bowel Diseases (IBD): Development and validation of a questionnaire (U-IBDQ). (27th May 2021) Authors: Ostromohov, G; Fiebelman, M; Hirsch, A; Ron, Y; Aviv Cohen, N; Kariv, R; Deutsch, L; Anbar, R; Maharshak, N; Fliss Isakov, N Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP01 Comparison of fecal transplantation, fecal transplantation with the novel UC diet or the UC diet alone for Refractory Mild to Moderate Active Ulcerative Colitis: The CRAFT UC randomized controlled trial. (27th May 2021) Authors: Levine, A; Scaldaferri, F; Sarbagili Shabat, C; Zittan, E; Hirsch, A; Mentella, M C; Musca, T; Cohen, N A; Ron, Y; Fliss Isakov, N; Pfeffer, J; Yaakov, M; Fanali, C; Turchini, L; Masucci, L; Quaranta, G; Anastasia, G; Weinberger, A; Kopylov, U; Maharshak, N Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P101 Fecal calprotectin is increased among patients with pouchitis and increases with increasing endoscopic subscores: Real-world data from a prospectively collected database. (27th May 2021) Authors: Ollech, J; Bannon, L; Maharshak, N; Tulchinsky, H; Yanai, H; Dotan, I Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P275 Course of COVID-19 in patients with Inflammatory Bowel Diseases treated with biologics: the Israeli experience. (27th May 2021) Authors: Lichtenstein, L; Koslowsky, B; Avni-Biron, I; Ovadia, B; Ben-Bassat, O; Naftali, T; Kopylov, U; Haberman, Y; Banai Eran, H; Eliakim, R; Lahat-Zok, A; Hirsch, A; Zittan, E; Maharshak, N; Waterman, M; Israeli, E; Goren, I; Ollech, J E; Yanai, H; Ungar, B Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P323 The Crohn's Disease Exclusion Diet (CDED) for pouch inflammation: an interventional pilot study. (21st January 2022) Authors: Fliss Isakov, N; Kornblum, J; Zemel, M; Hirsch, A; Maharshak, N Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P384 Postoperative Endoscopic Recurrence In Patients With Crohn's Disease After "Curative" Ileocecal Resection on Prophylaxis Treatment With Either Anti-TNFs, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study. (21st January 2022) Authors: Yanai, H; Amir Barak, H; Kagramanova, A; Knyazev, O; Sabino, J; Haenen, S; Mantzaris, G J; Mountaki, K; Pugliese, D; Armuzzi, A; Furfaro, F; Fiorino, G; Drobne, D; Kurent, T; Yassin, S; Maharshak, N; Castiglione, F; Nardone, O M; de Sire, R; Farkas, K Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P442 Serum vedolizumab trough levels are associated with remission rate but not with extra-intestinal manifestations in IBD patients. (27th May 2021) Authors: Tzadok, R; Fliss-Isakov, N; Aviv Cohen, N; Ron, Y; Maharshak, N; Hirsch, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P473 Real world experience with the Crohn's Disease Exclusion Diet (CDED) in a tertiary IBD clinic. (21st January 2022) Authors: Fliss Isakov, N; Anbar, R; Cooperstein, A; Helbert, G; Hirsch, A; Ron, Y; Thurm, T; Maharshak, N Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗